ES464747A1 - Tetralines - Google Patents

Tetralines

Info

Publication number
ES464747A1
ES464747A1 ES464747A ES464747A ES464747A1 ES 464747 A1 ES464747 A1 ES 464747A1 ES 464747 A ES464747 A ES 464747A ES 464747 A ES464747 A ES 464747A ES 464747 A1 ES464747 A1 ES 464747A1
Authority
ES
Spain
Prior art keywords
carbon atoms
hydrogen
alkyl
group
ch2oh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES464747A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES464747A1 publication Critical patent/ES464747A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Process for obtaining 2-amino-1,2,3,4-tetrahydro-naphthalene derivatives of formula I, ** (Formula) ** where R1 is hydrogen, alkanoyl of 1 to 20 carbon atoms or a group -CO- (CH2) n-R7, R2 is hydrogen, hydroxy, alkanoyloxy of 1 to 20 carbon atoms, a group -O-CO- (CH2) n-R7, halogen, alkyl of 1 to 4 carbon atoms, an alkyl sulfonylamino group of 1 to 4 carbon atoms, a CF3SO2NH, CCl3SO2NH, CH2OH, CH2-O- CO- (CH2) n-R7 or CH2-O-CO-R8 group, wherein R8 is hydrogen or alkyl from 1 to 19 carbon atoms, R3 is hydrogen or when R2 is chlorine it also means chlorine, R4 is hydrogen, CH2OH, CH2O-CO-R8 or CH2-O-CO- (CH2) n-R7, R5 is hydrogen, alkyl from 1 to 4 carbon atoms, cycloalkyl from 3 to 8 carbon atoms or (CH2) n-R9, R6 is hydrogen or alkyl from 1 to 4 carbon atoms, or R5 and R6, together, signify a group - (CH2) 4- (CH2) 5 or - (CH2) 6. (Machine-translation by Google Translate, not legally binding)
ES464747A 1976-12-07 1977-12-05 Tetralines Expired ES464747A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1535376 1976-12-07
CH8277 1977-01-05

Publications (1)

Publication Number Publication Date
ES464747A1 true ES464747A1 (en) 1979-01-01

Family

ID=25683446

Family Applications (1)

Application Number Title Priority Date Filing Date
ES464747A Expired ES464747A1 (en) 1976-12-07 1977-12-05 Tetralines

Country Status (17)

Country Link
JP (1) JPS5384955A (en)
AT (1) AT366361B (en)
CA (1) CA1105475A (en)
DE (1) DE2752659A1 (en)
DK (1) DK527877A (en)
ES (1) ES464747A1 (en)
FI (1) FI773595A (en)
FR (1) FR2373513A1 (en)
GB (1) GB1597140A (en)
IE (1) IE45929B1 (en)
IL (1) IL53533A (en)
NL (1) NL7713364A (en)
NZ (1) NZ185884A (en)
PH (1) PH13932A (en)
PT (1) PT67365B (en)
SE (1) SE7713471L (en)
SU (1) SU927110A3 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000251A1 (en) * 1978-07-14 1980-02-21 American Hospital Supply Corp Derivatives of 2-amino-6,7-dihydroxytetrahydronaphthalene(adtn)
US4314082A (en) * 1978-07-14 1982-02-02 American Hospital Supply Corporation Derivatives of 2-amino-6,7-dihydroxytetrahydro naphthalene (ADTN)
EP0026848B1 (en) 1979-09-14 1983-05-04 Sandoz Ag Derivatives of tetraline, their preparation and medicaments containing these compounds
EP0033789B1 (en) * 1980-01-30 1984-03-07 American Hospital Supply Corporation 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, its salts, and a process for preparation thereof
SE8004002L (en) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik THERAPEUTICALLY APPLICABLE TETRALIN DERIVATIVES
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
AU8455082A (en) * 1981-05-11 1982-12-07 Folk Lars-Erik Arvidsson Therapeutically useful tetralin derivatives iii,processes forpreparation and pharmaceutical preparations for such compounds
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4402974A (en) 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
IT1218322B (en) * 1982-06-10 1990-04-12 Chiesi Farma Spa 1,2,3,4-TETRAIDRONAFTALENE DERIVATIVES, PREPARATION PROCEDURE AND RELATED PHARMACEUTICAL COMPOSITIONS
US4448990A (en) * 1982-11-16 1984-05-15 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US4500545A (en) * 1982-11-16 1985-02-19 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US4743618A (en) * 1983-01-03 1988-05-10 Nelson Research & Development Co. Substituted 2-aminotetralins
US4722933A (en) * 1985-12-20 1988-02-02 Nelson Research & Development Co. Substituted 2-aminotetralins
US4564628A (en) * 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
US5177112A (en) * 1983-01-03 1993-01-05 Whitby Research, Inc. Substituted 2-aminotetralins
US4657925A (en) * 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
GB2157950B (en) * 1984-05-04 1988-11-02 Nelson Res & Dev Selective d-2 dopamine receptor agonist
CA1331191C (en) 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
JP2931986B2 (en) * 1989-02-17 1999-08-09 武田薬品工業株式会社 Aralkylamine derivatives
SE8901889D0 (en) * 1989-05-26 1989-05-26 Astra Ab NOVEL 8-SUBSTITUTED-2-AMINOTETRALINES
EP0639557A1 (en) * 1991-03-07 1995-02-22 Zeria Pharmaceutical Co., Ltd. Trialkylamine derivative and ameliorant for digestive tract movement containing the same
CZ370198A3 (en) * 1996-05-31 1999-05-12 Pharmacia & Upjohn Company Aryl substituted cyclic amines as selective dopamine d3 ligands
IT1294931B1 (en) 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti DERIVATIVES OF 2-AMINOTETHRALIN PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, ACTIVE IN THE
AR054363A1 (en) * 2005-05-23 2007-06-20 Astrazeneca Ab COMPOUNDS THAT DISPLAY MODULATORY ACTIVITY IN THE 5-HYDROXY-TRIPTAMINE 6 RECEIVER
US8809590B2 (en) * 2011-06-27 2014-08-19 Shan Dong Luye Pharmaceutical Co., Ltd. Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1017359A (en) * 1972-07-03 1977-09-13 Frederic P. Hauck Substituted cyclic polymethylene phenols

Also Published As

Publication number Publication date
NL7713364A (en) 1978-06-09
AT366361B (en) 1982-04-13
JPS6214540B2 (en) 1987-04-02
NZ185884A (en) 1980-04-28
FR2373513B1 (en) 1980-08-22
IL53533A0 (en) 1978-03-10
IE45929B1 (en) 1982-12-29
DK527877A (en) 1978-06-08
PT67365B (en) 1979-09-20
FR2373513A1 (en) 1978-07-07
PT67365A (en) 1978-01-01
SU927110A3 (en) 1982-05-07
CA1105475A (en) 1981-07-21
PH13932A (en) 1980-11-04
FI773595A (en) 1978-06-08
JPS5384955A (en) 1978-07-26
SE7713471L (en) 1978-06-08
DE2752659A1 (en) 1978-06-08
IE45929L (en) 1978-06-07
IL53533A (en) 1982-07-30
GB1597140A (en) 1981-09-03
ATA871977A (en) 1981-08-15

Similar Documents

Publication Publication Date Title
ES464747A1 (en) Tetralines
RO82370B (en) Process for preparing 9-amino-dibenzopyran derivatives
ES450245A1 (en) 2-substituted oxazolo(4,5-b)pyridine anti-inflammatory agents
DE3372095D1 (en) Novel phenylpiperazine derivatives and process for producing the same
ES445661A1 (en) Acetylene derivatives
ES464045A1 (en) Preparation of gamma-pyrones from 3-substituted furans
ES454823A1 (en) Derivatives of imidazo 1,2-a pyridine
IL58311A0 (en) Isomerisation of 3-azabicyvlo (3.1.0)hexane derivatives
ES456912A1 (en) 5(6)-benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
ES453121A1 (en) Substituted aminoalkylaminopyridine compounds
ES473437A1 (en) Tetracyclic compounds
ES286808A1 (en) A procedure for the preparation of benzoxazepin derivatives (Machine-translation by Google Translate, not legally binding)
ES462647A1 (en) Tetrabenzocycloheptenes
ES471124A1 (en) Procedure for preparing oxamic acid derivatives (Machine-translation by Google Translate, not legally binding)
ES443200A1 (en) Hexahydroindolinol derivatives
ES460297A1 (en) 6,11-dihydrodibenzo-(b. e.)-thiepin-11-one-3-aldehyde and 3-acetal derivatives
ES465366A2 (en) 2-methoxybenzamides
ES459400A1 (en) 6,11-dihydrodibenzo - thiepin - 11 - ones methods of preparation compositions and uses thereof
ES479060A1 (en) Procedure for preparing naftalene derivatives. (Machine-translation by Google Translate, not legally binding)
ES454325A1 (en) A procedure for the preparation of new derivatives of indan-1,3-diona. (Machine-translation by Google Translate, not legally binding)
ES466128A1 (en) A procedure for the preparation of 4-desacetil-indol- dihidroindol dimero. (Machine-translation by Google Translate, not legally binding)
ES485967A1 (en) A procedure for the preparation of new heterociclic derivatives of cumarina (Machine-translation by Google Translate, not legally binding)
ES460517A3 (en) Procedure for the obtaining of tiometil aril ureas. (Machine-translation by Google Translate, not legally binding)
ES417269A1 (en) 3-azetidinylethyl-1-phenyl-2-midazolidinone derivatives
ES407263A1 (en) Procedure for the obtaining of pleuromutilines. (Machine-translation by Google Translate, not legally binding)